Ad hoc Announcement according to §15 WpHG
QIAGEN to conduct an up to US$100 million share repurchase program
Venlo, The Netherlands, April 27, 2016 – QIAGEN N.V. announces that its Managing Board, upon authorization of the Supervisory Board, has passed a resolution to exercise the authorization granted by the General Meeting of Shareholders on June 23, 2015, and to purchase shares in the Company up to a total of US$100 million (or the equivalent Euro amount thereof, in each case excluding transaction costs). Based on the closing price on April 26, 2016, this represents a repurchase volume of approximately four million shares. The repurchase program is scheduled to begin at the earliest on April 28, 2016, and to be completed on December 23, 2016, or if the upcoming General Meeting of Shareholders will extend the authorization to repurchase shares for another year, on December 21, 2017, at the latest. Details of the repurchase program will be announced before its actual commencement in line with Article 4, Section (2) of EC regulation 2273/2003 or, in case the announcement takes place from July 3, 2016, onwards, in line with Article 5 Section (1) and (6) of the then applicable EU regulation 596/2014 in conjunction with the regulatory technical standards adopted by the European Commission (so called Safe Harbour Regulation). Repurchased shares will be held in treasury in order to satisfy obligations for exchangeable debt instruments and employee share-based remuneration plans.
5912 PL Venlo
Frankfurt Stock Exchange, Regulated Market (Prime Standard)
Contacts QIAGEN N.V.:
John Gilardi, Tel: +49 2103 29 11711; firstname.lastname@example.org
Thomas Theuringer, Tel: +49 2013 29 11826 email@example.com